Update, November 16, 2026
Since the November 3 report, CHD has risen 1.0% today and 2.55% over the past five days, outpacing the broader market (SPY ‑0.45%) and matching the sector’s strength (+2.12% XLP), reinforcing the bullish bias. The picture holds – the stock remains perched at its 52‑week high of $114.14, comfortably above the 52‑week high support (114.14) and the swing‑zone at $103.39, while the breakout target of $125 and the stop at $113.46 are unchanged.
Technical metrics stay supportive: the 50‑day SMA sits at $101.71, the 200‑day SMA at $98.78, and RSI has nudged above 70, indicating overbought conditions that historically precede modest pull‑backs (median 1‑month move ≈ 0.9%). The daily trend continues to ride the weekly uptrend, and CHD still leads the S&P 500 (+14.4% over 50 days) and the consumer‑staples index XLP (+3.7% over 50 days). A weekly close below the swing‑zone at $100.27 would be the first change to the picture.
Analyst sentiment remains bullish, with TD Cowen raising its price target to $115 after strong Q3 results; see the full note on Investing.com. Insider sales have been modest, and the next earnings release is slated for January 29, 2027.
Church & Dwight (CHD) traded at $109.63 on November 3, 2026, 0.7% below its 52-week high of $110.45 set a day earlier. The rally followed a third-quarter report that beat estimates and raised the full-year outlook. For the next two to six weeks the balance of evidence leans positive, with high conviction: the daily and weekly trends agree, and CHD is outrunning both the S&P 500 and the staples sector. The shares already sit near the average analyst target, which limits how much valuation can help.
Why it matters
On October 30, 2026, CHD reported adjusted earnings of 92 cents a share against a consensus of 90 cents, on revenue of $1.602 billion, up 1%. The headline revenue figure undersells the quarter. According to the Motley Fool transcript, organic sales grew 5.1% against a 3% outlook, driven by 4.6% volume growth, and gross margin widened 170 basis points to 46.8%. Management then raised its 2026 organic growth outlook to about 5% and guided fourth-quarter adjusted EPS up 17% to 19%, Seeking Alpha reported. A new $1 billion share repurchase program came with it, Benzinga noted. The 10-Q shows net income up 16% to $212.2 million and diluted EPS up 19%. Growth came from volume and margin, not just price.
Much of this was anticipated. The stock is up 16.2% over the past month and 30.7% year to date, and its 14-day RSI is 67.5, close to the overbought zone. On October 28, before the report, Benzinga flagged CHD for an RSI of 71.1 after a gain of about 10% in a month. Even so, buyers kept paying up after the numbers, and the peak close came on November 2. Today's 0.7% dip is on volume 52.9% below the 20-day average, so it shows little selling pressure.
The five-day move splits cleanly. CHD gained 4.3%, while the S&P 500 fell 2.1%, so the market contributed nothing. The staples sector (XLP) rose 2.4%, which accounts for about half the move. The remaining 1.9 points is the stock's own, and that is the part the earnings beat explains.
No articles in our feed set out a dated bull-versus-bear argument on CHD, so the debate has to be inferred from the company's own disclosures. The positive side is the quality of the beat: volume-led growth, margin recovery and a raised outlook. The cautious side is also in management's commentary. Per Seeking Alpha, conditions remain challenging because of inflationary pressure tied to the Middle East conflict and rising global transportation rates. That is a cost risk to the margin gains that drove the quarter. Reported revenue growth of only 1%, against 5.1% organic, also means the underlying strength is not yet visible in the top line.
Valuation leaves little cushion. Nineteen analysts rate the stock a consensus buy, with a mean price target of about $108.95, a low of $78 and a high of $124. At $109.63 the shares trade 0.6% above the mean target and within reach of the highest one. The stock has moved ahead of the analysts rather than the other way round.
What the evidence says
The long-term trend is intact. Price is above its 40-week average and above the 10-week average, and the 50-day average ($99.68) sits above the 200-day ($97.92). The stock has risen 34.4% from its 52-week low of $81.60. It is in an advanced uptrend phase, extended after a sharp monthly gain but not broken.
For the next two to six weeks the balance of evidence leans positive. Conviction is high, at 3 of 4 points. The daily trend runs with the weekly uptrend. CHD leads the S&P 500 by 11.9% over 50 days and leads XLP by 4.6%. Strength relative to both the market and its own sector is the kind of confirmation that usually separates a durable move from a one-day earnings pop.
The strongest case against is stretch. The stock is up 16.2% in a month, its RSI is 67.5, it trades above the mean analyst target, and today's volume is running well under the 20-day average, so the latest push to the high has had little participation. XLP also fell 1.7% today, a reminder that the sector bid can fade. A pause or pullback toward the $100s would fit that picture without damaging the trend. These points are why conviction is not a full 4 of 4, but they do not outweigh an aligned trend and leadership over both benchmarks.
Levels that matter
The structure stands above $102.71, a swing zone. A move below it would be the first crack. The trend ends below $100.27, the next swing zone, which sits just above the 50-day average at $99.68. Beneath that are the 200-day average at $97.92 and a further swing zone at $96.82. The cluster of support between roughly $100 and $103 marks where earlier buyers stepped in.
The breakout level is a daily close above $110.45, the 52-week high, on volume above its 20-day average. Volume is the missing ingredient today. From that level the math gives targets at $125 and $150, both round numbers, against a stop at $102.08, a quarter of an ATR under the $102.71 swing zone. The first target offers 1.7 to 1, short of 3 to 1. The second offers 4.7 to 1, so the overall setup clears the 3-to-1 threshold, though only by way of the distant $150 level. Note that $125 sits just above the $124 high analyst target.
What would change the picture
A weekly close below $100.27 would change the picture, because it would break the swing zone that defines the uptrend and put the 50-day average in play. The non-price fact that would most likely do it is a cut to guidance, specifically if Middle East-related inflation and freight costs erode the 46.8% gross margin and force management to lower the roughly 5% organic growth outlook.
What to watch
- Next earnings, January 29, 2027: the number that matters is organic sales growth against the roughly 5% full-year outlook, with fourth-quarter adjusted EPS growth of 17% to 19% as the benchmark.
- Sector: XLP has risen 10.8% in a month, so a reversal in staples can pull CHD down before any company news. Transportation rates and Middle East-linked input costs are the sector items most relevant to margins.
- Valuation: at $109.63 the stock is 0.6% above the $108.95 mean price target, with the highest target at $124. Further gains depend on estimates rising, not on analysts already seeing upside.